BGB-3111-1002

Completed

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

Beigene Study ID info

BGB-3111-1002

ClinicalTrials.gov ID info

Clinical Drug Trials ID info

CTR20160204

Study Overview

Sex: All

Age: 18 Years to 75 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years to 75 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

You will be redirected to

Click the link above to continue or CANCEL